Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study using the OpenSAFELY platform

Zheng B., Green ACA., Tazare J., Curtis HJ., Fisher L., Nab L., Schultze A., Mahalingasivam V., Parker EPK., Hulme WJ., Bacon SCJ., DeVito NJ., Bates C., Evans D., Inglesby P., Drysdale H., Davy S., Cockburn J., Morton CE., Hickman G., Ward T., Smith RM., Parry J., Hester F., Harper S., Mehrkar A., Eggo RM., Walker AJ., Evans SJW., Douglas IJ., MacKenna B., Goldacre B., Tomlinson LA.

DOI

10.1101/2022.05.22.22275417

Type

Preprint

Publication Date

23/05/2022

Permalink Original publication